BIOVEX GROUP, INC.

Profile

Company Names

BIOVEX GROUP, INC.

Addresses

34 COMMERCE WAY, WOBURN, MA 01801

Phone Numbers

781-376-4900

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DE

Total Amount Raised:

$37,983,547.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2009-11-05 
$18,883,547.00 
$39,277,778.00 
$20,394,231.00 
Equity 
1
2009-03-30 
$19,100,000.00 
$40,000,000.00 
$20,900,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PHILIP 
 
ASTLEY-SPARKE 
EXECUTIVE OFFICER, DIRECTOR
BIOVEX GROUP, INC.
J. 
SEBASTIEN 
CLEIFTIE 
DIRECTOR
BIOVEX GROUP, INC.   |  EYEGATE PHARMACEUTICALS INC
ROBERT 
 
COFFIN 
EXECUTIVE OFFICER, DIRECTOR
BIOVEX GROUP, INC.
SUZETTE 
 
DUTCH 
DIRECTOR
BIOVEX GROUP, INC.   |  TOLERA THERAPEUTICS INC   |  JUVENTAS THERAPEUTICS INC
STEPHEN 
 
GORGOL 
EXECUTIVE OFFICER
BIOVEX GROUP, INC.
PHILIPPE 
 
GUINOT 
DIRECTOR
BIOVEX GROUP, INC.
COLIN 
 
LOVE 
EXECUTIVE OFFICER
BIOVEX GROUP, INC.
REENIE 
P. 
MCCARTHY 
DIRECTOR
BIOVEX GROUP, INC.   |  ATREAON, INC.
LEN 
 
POST 
DIRECTOR
BIOVEX GROUP, INC.
STEVEN 
 
PRELACK 
DIRECTOR
BIOVEX GROUP, INC.   |  PIERIS PHARMACEUTICALS, INC.   |  AERPIO PHARMACEUTICALS, INC.
STEPHEN 
 
REEDERS 
DIRECTOR
CORTRIA CORP   |  BIOVEX GROUP, INC.   |  CARA THERAPEUTICS INC   |  VASCULAR PATHWAYS INC   |  BEACON ENDOSCOPIC CORP   |  BIOMEDIX VASCULAR SOLUTIONS INC   |  CHEETAH MEDICAL, INC.   |  AMBIO HOLDINGS, INC.   |  ZIPLINE MEDICAL INC   |  VITAL CONNECT, INC.   |  ACCUVEIN INC.   |  MVM III (2020) LP   |  MVM A LP   |  MVM C LP   |  MVM V (2021) LP   |  MVM V (2020) LP   |  MVM IV (2019) LP
SANDER 
 
SLOOTWEG 
DIRECTOR
BIOVEX GROUP, INC.
SOMU 
 
SUBRAMANIAM 
DIRECTOR
BIOVEX GROUP, INC.   |  ACHRONIX SEMICONDUCTOR CORP   |  RF ARRAYS INC   |  LIGHTWIRE INC   |  RESOLVE THERAPEUTICS LLC   |  DALI SYSTEMS CO. LTD.   |  TRELLIS BIOSCIENCE LLC   |  BIOSCALE INC   |  SILICON SPACE TECHNOLOGY CORP   |  JUVENTAS THERAPEUTICS INC   |  DIRECTED SENSING INC.   |  PRIVATE GROUP NETWORKS, INC.   |  PERCEPTIMED, INC.   |  SVELTE MEDICAL SYSTEMS INC   |  ALEXAR THERAPEUTICS, INC.   |  NEW SCIENCE VENTURES FUND III, L.P.   |  NEW SCIENCE VENTURES FUND III (OFFSHORE), L.P.   |  VASCULAR THERAPIES INC   |  NSV 2016 OPPORTUNITIES FUND, L.P.   |  NSV 2016 OPPORTUNITIES FUND (OFFSHORE), L.P.   |  NSV 2017 OPPORTUNITIES FUND, L.P.   |  RALEXAR THERAPEUTICS, INC.   |  NSV 2018 NEW HORIZONS FUND, L.P.   |  NSV 2018 OPPORTUNITIES FUND, L.P.   |  NSV 2020 PREFERRED LP FUND, L.P.   |  NSV GROWTH OPPORTUNITIES FUND, L.P.   |  NSV 2021 GROWTH OPPORTUNITIES FUND, L.P.   |  PHASE FOUR, INC.   |  PAKAL TECHNOLOGIES, INC.   |  BRIGHTVOLT, INC   |  ABL SPACE SYSTEMS CO   |  GLYDWAYS, INC.   |  FERRIC, INC.
JAN 
 
VAN HEEK 
DIRECTOR
BIOVEX GROUP, INC.   |  MINERVA NEUROSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2009-11-12
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2009-11-05 
2009-04-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2009-03-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#